ARCHIVES

Piedmont, Mid-Atlantic Organizations Win Competition for NCI Support Of New Regional Cooperative Groups

This article is from The Cancer Letter archive.

Vol. 08 No. 16 | April 16, 1982

Download PDF Visit The Full Archive

Related Articles

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

August 27, 2010

Biomedical Panel To Hear Public At Sept. Meeting

July 11, 1975

Treatment IND or GM-CSF Is Approved

October 5, 1990

Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board

June 17, 2011

FDA Approves Lymphoseek For Imaging Lymph Nodes

March 29, 2013

In Brief: Medical School Deans Biggest Enemy Of Cancer Program, Saunders Says; House Oks Line Item

May 16, 1980